Because atorvastatin inhibits autocrine AKT phosphorylation in IMCs ex vivo (Fig. 4), we investigated whether long-term atorvastatin treatment affects AKT phosphorylation in tumour-associated myeloid populations in vivo. The gene discussed is AKT1; the disease is neoplasm.